Sepsis Clinical Trial
Official title:
Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care in Turkey
In this observational study, it is aimed to investigate the mortality and morbidity rates of hospital-acquired blood stream infections that are treated in intensive care units (ICU). The effects of properties of the micro-organism such as type and antimicrobial resistance on the infection and its outcomes will be mainly explored. In addition, the impact of antibiotic options and other treatment modalities on survival of patients will be investigated. Twenty-seven different ICUs from Turkey will be included in this study.
Blood stream infection (BSI) is defined as the identification of a culprit pathogen in the
blood culture sample of a participant. As such, and once contaminants are excluded, BSI is
the only cause of sepsis where the presence of an infection and the pathogen are known with
certainty. This makes BSI the perfect model of infection to study the effects of the
micro-organism on the participant, and the effects of the antibiotics and other treatments on
survival. There is an increasing trend in antimicrobial resistance rates among microorganisms
that are associated with nosocomial infections treated in ICU. However, infectious diseases
physicians from Turkey do not know contemporary epidemiological data of hospital-acquired BSI
treated in ICU in Turkey.
This study 'Epidemiology and Determinants of Outcomes of Hospital-Acquired Blood Stream
Infections in the Intensive Care in Turkey' is a multi-center prospective observational
cohort study that will include patients with hospital-acquired blood stream infections
(HA-BSI) treated in ICUs in Turkey. This study will present unknown current epidemiology of
HA-BSI in Turkey. Furthermore, It will provide very important data about 28-day mortality
rates of HA-BSI treated in ICU. The primary outcomes of this study can be accounted as
following: (i)determinants of outcomes of HA-BSI, (ii) the effects of the source of infection
on outcomes, (iii) the effects of microorganism on these outcomes, (iv) the effects of
antimicrobial therapy and of source control on investigated outcomes. In this study,
participant specific and organizational factors will be explored and the determinants of
management of HA-BSI in ICUs will be described.
There will be no intervention in this study. The data of participants will be obtained from
hospital database and recorded into electronic case report forms anonymously.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
| Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
| Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
| Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
| Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
| Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
| Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
| Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
| Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
| Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
| Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
| Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
| Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
| Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
| Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
| Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
| Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
| Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
| Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 | |
| Not yet recruiting |
NCT04516395 -
Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae
|
N/A |